In what is being described as the first ever and most comprehensive study of the effects of genetically modified foods on mammalian health, researchers have linked organ damage with consumption of Monsanto’s GM maize.
All three varieties of GM corn, Mon 810, Mon 863 and NK 603, were approved for consumption by US, European and several other national food safety authorities. Made public by European authorities in 2005, Monsanto’s confidential raw data of its 2002 feeding trials on rats that these researchers analyzed is the same data, ironically, that was used to approve them in different parts of the world.
The Committee of Research and Information on Genetic Engineering (CRIIGEN) and Universities of Caen and Rouen studied Monsanto’s 90-day feeding trials data of insecticide producing Mon 810, Mon 863 and Roundup® herbicide absorbing NK 603 varieties of GM maize.
The data “clearly underlines adverse impacts on kidneys and liver, the dietary detoxifying organs, as well as different levels of damages to heart, adrenal glands, spleen and haematopoietic system,” reported Gilles-Eric Séralini, a molecular biologist at the University of Caen.
Although different levels of adverse impact on vital organs were noticed between the three GMOs, the 2009 research shows specific effects associated with consumption of each GMO, differentiated by sex and dose.
Their December 2009 study appears in the International Journal of Biological Sciences (IJBS). This latest study conforms with a 2007 analysis by CRIIGEN on Mon 863, published in Environmental Contamination and Toxicology, using the same data.
Monsanto rejected the 2007 conclusions, stating: “The analyses conducted by these authors are not consistent with what has been traditionally accepted for use by regulatory toxicologists for analysis of rat toxicology data.”1